AAN: Over-the-Counter Pain Relivers Tied to Fewer Concussion Symptoms
By Lori Solomon HealthDay Reporter
MONDAY, March 17, 2025 -- People who take over-the-counter (OTC) pain relievers after a concussion may recover faster than those who do not, according to a study scheduled for presentation at the annual meeting of the American Academy of Neurology, to be held from April 5 to 9 in San Diego.
Kyle Arnold, M.D., from the University of Washington in Seattle, and colleagues evaluated the effect of OTC analgesics on clinical outcomes after concussion. Analysis included 813 college athletes and military cadets who had concussions and took over-the-counter pain relievers (acetaminophen, ibuprofen, or other nonsteroidal anti-inflammatory drugs) and 848 who did not take any pain relievers.
The researchers found that compared to those who did not take pain relievers, people who took the pain relievers were 20 percent more likely to have a faster time before they were cleared to return to activities with no restrictions. On average, those who took the medications were cleared at 50 percent recovery two days faster, and at 90 percent recovery seven days faster versus those who took no medication. Participants who took pain relievers were 15 percent more likely to return to having no symptoms more quickly, compared to those who did not take pain relievers. Lastly, those who started using OTC pain relievers on the first day of their injury returned to play and had resolution of symptoms at 50 percent recovery eight days faster than those who started taking pain relievers after five or more days.
"These preliminary results may help inform potential treatment options for people recovering from concussions, but additional studies are needed to provide more definitive recommendations," Arnold said in a statement.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-03-18 06:00
Read more

- Duke Doctors Perform First Living Mitral Valve Transplant
- FDA Approves Romvimza (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor
- Amgen and Kyowa Kirin Provide Top-Line Results from Rocatinlimab Phase 3 Ignite Study in Adults with Moderate to Severe Atopic Dermatitis
- Psychosomatic Misdiagnosis Can Have Lasting Negative Impact on Patients
- Depression Tied to Having More Physical Health Conditions
- 1990 to 2023 Saw 14 Percent Decrease in Actual Number of U.S. Births
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions